Cross-Sensitivity of Methylating Agents, Hydroxyurea, and Methotrexate in Human Tumor Cells of the Mer- Phenotype K Maynard, PG Parsons Cancer research 46 (10), 5009-5013, 1986 | 40 | 1986 |
Relationships among Cell Survival, O6-Alkylguanine-DNA Alkyltransferase Activity, and Reactivation of Methylated Adenovirus 5 and Herpes Simplex Virus Type 1 … K Maynard, PG Parsons, T Cerny, GP Margison Cancer research 49 (17), 4813-4817, 1989 | 25 | 1989 |
Single sensor gait analysis to detect diabetic peripheral neuropathy: a proof of principle study P Esser, J Collett, K Maynard, D Steins, A Hillier, J Buckingham, GD Tan, ... Diabetes & Metabolism Journal 42 (1), 82, 2018 | 23 | 2018 |
Use of host cell reactivation of cisplatin-treated adenovirus 5 in human cell lines to detect repair of drug-treated DNA. KR Maynard, LK Hosking, BT Hill Chemico-biological interactions 71 (4), 353-365, 1989 | 13 | 1989 |
Adenovirus replication as an in vitro probe for drug sensitivity in human tumors PG Parsons, KR Maynard, JH Little, GR McLeod European Journal of Cancer and Clinical Oncology 22 (4), 401-409, 1986 | 13 | 1986 |
Pain free blunt needle injection technology P Crocker, K Maynard, M Little Innov Pharm Technol 9, 111-115, 2001 | 5 | 2001 |
Decreased calcium dependence of lymphoblastoid cell lines compared with Burkitt lymphoma cell lines PG Parsons, DJ Moss, C Morris, P Musk, K Maynard, R Partridge International journal of cancer 35 (6), 743-747, 1985 | 4 | 1985 |
MELPHALAN‐RESISTANT LYMPHOBLASTOID CELL LINES ESTABLISHED FROM PATIENTS WITH OVARIAN CANCER TREATED WITH CROSS‐LINKING AGENTS K Maynard, P Musk, B Daunter, SK Khoo, PG Parsons Australian journal of experimental biology and medical science 63 (3), 333-341, 1985 | 4 | 1985 |
DepotOne: a technology to make large needle injections more acceptable K Maynard, P Croker, M Little DRUG DELIVERY SYSTEMS AND SCIENCES 3, 71-74, 2003 | 1 | 2003 |
Improving the Delivery of Complex Formulations Using the DepotOne Needle K Maynard, P Crocker Modified-Release Drug Delivery Technology, 187-198, 2008 | | 2008 |
From pain to gain K Maynard DRUG DELIVERY SYSTEMS AND SCIENCES 5 (2), 49, 2005 | | 2005 |
NOVEL METHODS FOR INCREASING THE NUMBER OF CLONES EXPRESSING SENSITIVITY TO A CYTO-TOXIC AGENT IN A TUMOR-CELL POPULATION K MAYNARD, BT HILL BRITISH JOURNAL OF CANCER 60 (3), 495-495, 1989 | | 1989 |
Resistance to alkylating agents in human melanoma and lymphoblastoid cells KR Maynard University of Queensland, 1986 | | 1986 |
THE MER-PHENOTYPE IN HUMAN-MELANOMA CELL-LINES K MAYNARD, PG PARSONS PROCEEDINGS OF THE AUSTRALIAN BIOCHEMICAL SOCIETY 16, 99-99, 1984 | | 1984 |